Learn More
Medchemexpress LLC SK1-I (BML-258) | 1072443-89-0 | 98.8% | 277.40 g·mol⁻¹ | C17H27NO2 | 50 MG

Supplier: Medchemexpress LLC HY11901650MG
SK1-I (BML-258) is a sphingosine analog and an isozyme-selective, competitive inhibitor of sphingosine kinase 1 (SPHK1). It has a reported Ki of approximately 10 μM and has been shown to enhance autophagy and exhibit antitumor activity in preclinical studies. Supplied as a 50 mg powder for research use only.
- Isozyme-selective competitive SPHK1 inhibitor (Ki ≈ 10 μM)
- Sphingosine analog with autophagy-enhancing effects
- Reported antitumor activity in preclinical models
- High purity (98.83%) suitable for research applications
- Storage: powder stable at -20 °C (3 years) or 4 °C (2 years)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.